NCT06566079
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06566079
Title Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors InSilico Medicine Hong Kong Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
The University of Chicago Medical Center - Duchossois Center for Advanced Medicine RECRUITING Chicago Illinois 60637 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
University of Pennsylvania - Abramson Cancer Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology - Austin RECRUITING Austin Texas 78758 United States Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan China Details
Cancer Hospital Chinese Academy of Medical Sciences RECRUITING Beijing China Details
Sun Yat-Sen University Cancer Center RECRUITING Guangzhou China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field